Release of growth factors by neuronal precursor cells as a treatment for diseases with tau pathology

Archives Italiennes de Biologie

Volumn 149, Issue 2, 2011, Pages 215-223

  Spilantini, M G ^a   Iovino, M ^a   Vuono, R ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Associated tau protein; Growth factors; Microtubule; Neurodegenerative diseases

Indexed keywords

4 AMINOBUTYRIC ACID; BRAIN DERIVED NEUROTROPHIC FACTOR; GLIAL FIBRILLARY ACIDIC PROTEIN; MAPT PROTEIN, HUMAN; PROLINE; SERINE; SIGNAL PEPTIDE; TAU PROTEIN;

ANALYSIS OF VARIANCE; ANIMAL; ARTICLE; C57BL MOUSE; CELL DIFFERENTIATION; DISEASE MODEL; FEMALE; GENETICS; HEMISPHERIC DOMINANCE; HUMAN; MALE; METABOLISM; METHODOLOGY; MOUSE; MUTATION; NEURAL STEM CELL; PHOSPHORYLATION; STEM CELL TRANSPLANTATION; TAUOPATHY; TIME; TRANSGENIC MOUSE;

ANALYSIS OF VARIANCE; ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL DIFFERENTIATION; DISEASE MODELS, ANIMAL; FEMALE; FUNCTIONAL LATERALITY; GAMMA-AMINOBUTYRIC ACID; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUTATION; NEURAL STEM CELLS; PHOSPHORYLATION; PROLINE; SERINE; STEM CELL TRANSPLANTATION; TAU PROTEINS; TAUOPATHIES; TIME FACTORS;

HOMO SAPIENS; MUS MUSCULUS;

EID: 79958169814     PISSN: 00039829     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Acsadi G., Anguelov R.A., Yang H., Toth G., Thomas R., Jani A., Wang Y., Ianakova E., Mohammad S., Lewis R.A., Shy M.E. Increased survival and function of SOD1 mice after glial cell-derived neurotrophic factor gene therapy. Hum Gene Ther., 13: 1047-1059, 2002.
2. Allen B., Ingram E., Takao M., Smith M.J., Jakes R., Virdee K., Yoshida H., Holzer M., Craxton M., Emson P.C., Atzori C., Migheli A., Crowther R.A., Ghetti B., Spillantini M.G., Goedert M. Abundant tau filaments and non-apoptotic neurodegeneration in transgenic mice expressing human P301S tau protein. J. Neurosci., 22: 9340-9351, 2002.
3. Bellucci A., Westwood A.J., Ingram E., Casamenti F., Goedert M., Spillantini M.G. Induction of inflammatory mediators and microglial activation in mice transgenic for mutant human P301S tau protein. Am. J. Pathol., 165: 1643-1652, 2004.
4. Blurton-Jones M., Kitazawa M., Martinez-Coria H., Castello N. A., Muller F.J., Loring J.F., Yamasaki T.R., Poon W.W., Green K.N., LaFerla F. Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease. Proc. Natl. Acad. Sci. USA, 106: 13594-13599, 2009.
5. Boucherie C., Schafer S., Lavand'homme P., Maloteaux J.M., Hermans E. Chimerization of astroglial population in the lumbar spinal cord after mesenchymal stem cell transplantation prolongs survival in a rat model of amyotrophic lateral sclerosis. J. Neurosci. Res., 87: 2034-2046, 2009.
6. Braak H. and Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol., 82: 239-259, 1991.
7. Broe M., Kril J., Halliday G.M. Astrocytic degeneration relates to the severity of disease in frontotemporal dementia. Brain, 127: 2214-2220, 2004.
8. Bugiani O., Murrell J.R., Giaccone G, Hasegawa M., Ghigo G., Tabaton M., Morbin M., Primavera A, Carella F., Solaro C., Grisoli M., Savoiardo M., Spillantini M.G., Tagliavini F., Goedert M., Ghetti B. Frontotemporal dementia and corticobasal degeneration in a family with a P301S mutation in tau. J. Neuropath. Exp. Neurol., 58: 667-677, 1999.
9. Cao Q.L., Zhang Y.P., Howard R.M., Walters W.M., Tsoulfas P., Whittemore S.R. Pluripotent stem cells engrafted into the normal or the lesioned adult rat spinal cord are restricted to a glial lineage. Exp. Neurol., 167: 48-58, 2001.
10. Davies J.E., Huang C., Pröschel C., Noble M., Mayer-Pröschel M., Davies S.J. Astrocytes derived from glial-restricted precursors promote spinal cord repair. J. Biol., 5: 7, 2006.
11. Delobel P., Lavenir I., Fraser G., Ingram E., Holzer M., Ghetti B., Spillantini M.G., Crowther R.A., Goedert M. Analysis of tau phosphorylation and truncation in a mouse model of human tauopathy. Am. J. Pathol., 172: 123-131, 2008.
12. Ferri C.P., Prince M., Brayne C., Brodaty H., Fratiglioni L., Ganguli M., Hall K., Hasegawa K., Hendrie K., Huang Y., Jorm A., Mathers C., Menezes P.R., Rimmer E., Scazufca M. Global prevalence of dementia: a Delphi consensus study. Lancet, 366: 2112-2117, 2005.
13. Furman S., Steingart R.A., Mandel S., Hauser J.M., Brenneman D.E., Gozes I. Subcellular localization and secretion of activity-dependent neuroprotective protein in astrocytes. Neuron. Glia. Biol., 1: 193-199, 2004.
14. Gage F.H. Mammalian neural stem cells. Science, 287: 1433-1438., 2000.
15. Gasparini L., Anthony Crowther R., Martin K.R., Berg N., Coleman M., Goedert M., Spillantini M.G. Tau inclusions in retinal ganglion cells of human P301S tau transgenic mice. Effects on axonal viability. Neurobiology Aging, 32: 419-433, 2009.
16. Gasparini L., Terni B., Spillantini M.G. Frontotemporal dementia with tau pathology. Neurodegenerative diseases, 4: 236-253, 2007.
17. Goedert M. and Spillantini M.G. A century of Alzheimer's disease. Science, 314: 777-781, 2006.
18. Goedert M., Spillantini M.G., Jakes R., Rutherford D., Crowther R.A. Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron, 3: 519-526, 1989.
19. Hampton D.W., Anderson J., Pryce G., Irvine K.A., Giovannoni G., Fawcett J.W., Compston A., Franklin R.J., Baker D., Chandran S. An experimental model of secondary progressive multiple sclerosis that shows regional variation in gliosis, remyelination, axonal and neuronal loss. J. Neuroimmunol., 202: 200-211, 2008.
20. Hampton D.W., Webber D.J., Bilican B., Goedert M., Spillantini M.G., Chandran S. Cell-mediated neuroprotection in a mouse model of human tauopathy. J. Neurosci., 30: 9973-9983, 2010.
21. Hess D.C. and Borlongan C.V. Stem cells and neurological diseases. Cell Prolif., 41 (Suppl 1): 94-114, 2008.
22. Hofstetter C.P., Holmstrom N.A., Lilja J.A., Schweinhardt P., Hao J., Spenger C., Wiesenfeld-Hallin Z., Kurpad S.N., Frisen J., Olson L. Allodynia limits the usefulness of intraspinal neural stem cell grafts; directed differentiation improves outcome. Nat. Neurosci., 8: 346-353, 2005.
23. Hutton M., Lendon C.L., Rizzu P., Baker M., Froelich S., Houlden H., Pickering-Brown S., Chakravety S., Isaacs A., Grover A., Hackett J., Adamson J., Lincoln S., Dickson D., Davies P., Peterson R.C., Stevens M., de Graff E., Wauters E., van Baren J., Hillebrand M., Joosse M., Kwon J.M., Nowotny P., Che L.K., Norton J., Morris J.C., Reed L.A., Trojanowski J., Basun H., Lannfelt L., Neystat M., Fahn S., Dark F., Tannenberg T., Dodd P.R, Hayward N., Kwok J.B., Schofield P.R., Andreadis A., Snowden J., Craufurd D., Neary D., Owen F., Oostra B.A., Hardy J., Goate A., van Swieten J., Mann D., Lynch T., Heutink P. Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature, 393: 702-705 1998.
24. Ittner L.M., Ke Y.D., Delerue F., Bi M., Gladbach A., van Eersel J., Woelfing H., Chieng B.C, Christie M.J., Napier I.A., Eckert A., Staufenbiel M., Hardeman E., Gotz J. Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models. Cell, 142: 387-397, 2010.
25. Kaspar B.K., Llado J., Sherkat N., Rothstein J. D., Gage F.H. Retrograde viral delivery of IGF-1 prolongs survival in a ALS mouse model. Science, 301: 839-842, 2003.
26. Kersaitis C., Halliday G.M., Kril J.J., Regional and cellular pathology in frontotemporal dementia: relationship to stage of disease in cases with and without Pick bodies. Acta Neuropathol., 108: 515-523, 2004.
27. Lee V.M., Goedert M., Trojanowski J.Q. Neurodegenerative tauopathies. Ann. Rev. Neurosci., 24: 1121-1159, 2001.
28. Lepore A.C., Rauck B., Dejea C., Pardo A.C., Rao M.S., Rothstein J.D., Maragakis N.J. Focal transplantation-based astrocyte replacement is neuroprotective in a model of motor neuron disease. Nat. Neurosci., 11: 1294-1301, 2008.
29. Leverenz J.B., Yu C.E., Montine T.J., Steinbart E., Bekris L.M., Zabetian C, Kwong L.K., Lee V.M., Schellenberg G.D., Bird T.D. A novel progranulin mutation associated with variable clinical presentation and tau, TDP43 and alpha-synuclein pathology. Brain, 130: 1360-1374, 2007.
30. Lewis J., McGowan E., Rockwwood J., Melrose H., Nacharaju P., Van Slegtenhorst M., Gwinn-Hardy K., Murphy P.M., Backer M., Yu X., Duff K., Hardy J., Korral A,. Lin W.L., Yen S.H., Dickson D.W., Davies P., Hutton M. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat. Genet., 25: 402-405, 2000.
31. Lu P., Jones L.L., Snyder E.Y., Tuszynski M.H. Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury. Exp. Neurol., 181: 115-129, 2003.
32. Mackenzie I.R., Foti D., Woulfe J., Hurwitz T.A. Atypical frontotemporal lobar degeneration with ubiquitin-positive, TDP-43-negative neuronal inclusions. Brain, 131: 1282-1293, 2008.
33. Maeda S., Sahara N., Saito Y., Murayama M., Yoshiike Y., Kim H., Miyasaka T., Murayama S., Ikai A., Takashima A. Granular tau oligomers as intermediates of tau filaments. Biochemistry, 46: 3856-3861, 2007.
34. Magnani E., Fan J., Gasparini L., Golding M., Williams M., Schiavo G., Goedert M., Amos L.A., Spillantini M.G. Interaction of tau protein with the dynactin complex. EMBO J. 26: 4546-4554, 2007.
35. Martino G. and Pluchino S. Therapeutic potential of neural stem cells. Nature Rev. Neurosci., 7: 395-406, 2006.
36. Oliveira A.J.R., Hodges H.M. Alzheimer's disease and neural transplantation as prospective cell therapy. Curr. Alzheimer Res., 2: 79-95, 2005.
37. Poorkaj P., Bird T.D., Wijsman E., Nemens E., Garruto R.M., Anderson L., Andreadis A., Wiederholt W.C., Raskind M., Schellenberg G.D. Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann. Neurol., 43: 815-825, 1998.
38. Prince M., Jackson J. World Alzheimer report. Alzheimer Disease Int., 1, 96, 2009.
39. Rosso S.M, Kamphors M.G., Heutink P., van Swieten J.C. Familial frontotemporal dementia with ubiquitin-positive inclusions is linked to chromosome 17q21-22. Brain, 124: 1948-1950, 2001.
40. Scattoni M.L., Gasparini L., Alleva E., Goedert M., Calamandrei G., Spillantini M.G. Early behavioural markers of disease in P301S tau transgenic mice. Behav. Brain Res., 208: 250-257, 2010.
41. Scott A.L., Borisoff J.F., Ramer M.S. Differentiation and neurotrophin mediated intraspinal sprouting: a central role for the p75 neurotrophin receptor. Eur. J. Neurosci., 21: 81-92, 2005.
42. Shiryaev N., Jouroukhin Y., Giladi E., Polyzoidou E., Grigoriadis N.C., Rosenmann H., Gozes I. NAP protects memory, increases soluble tau and reduces tau hyperphosphorylation in a tauopathy model. Neurobiol. Dis., 34: 381-388, 2009.
43. Spillantini M.G., Murrell J.R., Goedert M., Farlow M.R., Klug A., Ghetti B. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc. Nat.l Acad. Sci. U.S.A., 95: 7737-7741, 1998.
44. Sugaya K. Possible use of autologous stem cell therapies for Alzheimer's disease. Curr. Alzheimer Res., 2: 367-376, 2005.
45. Tan C.F., Piao Y.S., Kakita A., Yamada M., Takano H., Tanaka M., Mano A., Makino K., Nishizawa M., Wakabayashi K., Takahashi H. Frontotemporal dementia with co-occurrence of astrocytic plaques and tufted astrocytes, and severe degeneration of the cerebral white matter: a variant of corticobasal degeneration? Acta Neuropathol., 109: 329-338, 2005.
46. Tanne J.H. Activating stem cells may treat Alzheimer's. BMJ, 330: 622, 2005.
47. Vescovi A.L., Reynolds B.A., Fraser D.D., Weiss S. bFGF regulates the proliferative fate of unipotent (neuronal) and bipotent (neuronal/astroglial) EGFgenerated CNS progenitor cells. Neuron, 11: 951-966, 1993.
48. White R.E., Yin F.Q., Jakeman L.B. TGF-alpha increases astrocyte invasion and promotes axonal growth into the lesion following spinal cord injury in mice. Exp. Neurol., 214: 10-24, 2008.